Earnings

iRadimed Q3 Adj. EPS $0.55, Inline, Sales $24.203M Beat $23.467M Estimate

Oct 30, 2026 · 08:44 AM ET· updated 1h ago

iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.55 per share which met the analyst consensus estimate. This is a 17.02 percent increase over earnings of $0.47 per share from the same period last year. The

Why It Matters

iRadimed made more money per share than last year and beat sales predictions. When a company sells more than expected, it hints the business is growing strong.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

IRMD78.00

-7.74 (-9.03%)

MMM178.22

+0.85 (+0.48%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.